CN Patent

CN110505873B — 鼻内肾上腺素制剂及治疗疾病的方法

Assigned to Anders Pharmaceutical Operations Co · Expires 2022-12-30 · 3y expired

What this patent protects

提供了包含具有肾上腺素的制剂的适合于鼻腔递送的药物产品，以及包含这样的制剂的装置。还提供了用肾上腺素产品治疗过敏反应的方法。

USPTO Abstract

提供了包含具有肾上腺素的制剂的适合于鼻腔递送的药物产品，以及包含这样的制剂的装置。还提供了用肾上腺素产品治疗过敏反应的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110505873B
Jurisdiction
CN
Classification
—
Expires
2022-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Anders Pharmaceutical Operations Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.